In a panel on international collaboration in drug development, biotechnology pioneer Ananda Chakrabarty described a new approach to eradicating cancer.
Dr. Chakrabarty’s research, as described in the Journal of Commercial Biotechnology, uses proteins from naturally-occurring human bacterial symbionts to combat cancer. Bacteria such as Pseudomonas aeruginosa are able to live inside humans and have developed anti-cancer compounds to check cancer and protect their human hosts.
Read more in the January issue of the Journal of Commercial Biotechnology.